(3) the transition from normal epithelium to invasive carcinoma in both ESCC and EAC driven by sequential disruptions of molecular networks governing epithelial homeostasis
Blood 98:328a, 2001
The superior performance of H-LLC over LL suggests a dose-dependent benefit, and its dual action on both inflammation and epithelial repair may offer advantages over conventional agents such as mesalazine, which primarily target inflammatory mediators without directly enhancing barrier restoration
The New England Comparative Effectiveness Public Advisory Council (CEPAC), a nationally recognized independent appraisal committee for ICER, found that adding tirzepatide to background therapy is superior to background therapy alone in a vote of 13 yes to 0 no
Other drugs, including some chemotherapy agents and anticonvulsants, may also interfere with glutathione levels
The enhanced ORSC proliferation and migration due to morroniside treatment were partly rescued by a Wnt/-catenin signaling inhibitor, DKK1